Page 2 - Steven Robert Pacelli News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Steven robert pacelli. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Steven Robert Pacelli Today - Breaking & Trending Today

Raymond James Boosts DexCom (NASDAQ:DXCM) Price Target to $151.00

DexCom (NASDAQ:DXCM – Free Report) had its target price lifted by Raymond James from $147.00 to $151.00 in a report issued on Tuesday morning, Benzinga reports. They currently have a strong-buy rating on the medical device company’s stock. A number of other research analysts have also commented on DXCM. Piper Sandler upped their price target […] ....

United States , Raymond James , Steven Robert Pacelli , Piper Sandler , Leerink Partnrs , Washington Trust Advisors Inc , Valley National Advisers Inc , Harbour Investments Inc , Dexcom Company Profile , Jpmorgan Chase Co , Bartlett Co , Atlas Capital Advisors , Dexcom Inc , Securities Exchange Commission , Wells Fargo Company , Free Report , Moderate Buy , Com Stock Down , Get Free Report , Director Steven Robert Pacelli , Exchange Commission , National Advisers , Capital Advisors , Washington Trust Advisors , Trust Advisors , Dexcom Share ,

Securian Asset Management Inc. Decreases Holdings in DexCom, Inc. (NASDAQ:DXCM)

Securian Asset Management Inc. cut its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 14.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 27,791 shares of the medical device company’s stock after selling 4,684 shares during the […] ....

United States , Michael Jon Brown , Steven Robert Pacelli , Wells Fargo Company , Centaurus Financial Inc , Securities Exchange Commission , Exchange Commission , Fulton Bank , Fortis Capital Advisors , Morgan Stanley , Lincoln National Corp , Dexcom Inc , Valley National Advisers Inc , Securian Asset Management Inc , Jpmorgan Chase Co , Securian Asset Management , Free Report , Asset Management , Capital Advisors , National Advisers , National Corp , Get Free Report , Director Steven Robert Pacelli , Jon Brown , Dexcom Share , Dexcom Real Time ,

DexCom (NASDAQ:DXCM) Given New $147.00 Price Target at Raymond James

DexCom (NASDAQ:DXCM – Get Free Report) had its price target lifted by stock analysts at Raymond James from $131.00 to $147.00 in a report released on Wednesday, Benzinga reports. The firm currently has a “strong-buy” rating on the medical device company’s stock. Raymond James’ target price suggests a potential upside of 22.45% from the company’s […] ....

United States , Stifel Nicolaus , Raymond James , Leerink Partnrs , Stevenr Altman , Steven Robert Pacelli , Raymond Jame , Harbour Investments Inc , Dexcom Inc , Valley National Advisers Inc , Thompson Siegel Walmsley , Atlas Capital Advisors , Wells Fargo Company , Dexcom Company Profile , Securities Inc , Get Free Report , Com Stock Down , Director Steven , Director Steven Robert Pacelli , Capital Advisors , Valley National Advisers , National Advisers , Dexcom Share , Dexcom Real Time , Dexcom Daily , Nasdaq Dxcm ,